Tendon injuries are common musculoskeletal system disorders in clinical, but the regeneration ability of tendon is limited. Tendon stem cells (TSCs) have shown promising effect on tissue engineering and been used for the treatment of tendon injury.
| INTRODUC TI ON
Tendon is highly prone to injury during sports and other rigorous physical activities. 1 Tendinopathy is a common chronic musculoskeletal system disorders worldwide, which exerts a significant detrimental effect on the patients' life quality. Many treatments for tendinopathy have been applied in clinical practice to restore tendon function and maintain the patient's quality of life, including nonsteroid anti-inflammation drugs (NSAIDs) intake, administration of steroid injections and physical therapies. 2, 3 However, their effects are largely limited to pain control and tendon matrix reconstruction. Tendon stem cells (TSCs) were first isolated from human and mouse in 2007 and were confirmed subsequently in rat and rabbit tendons. [4] [5] [6] Tendon stem cells has characters of stem cell like self-renewal ability, multi-differentiation potential, colony formation ability, which enables them to differentiate into tenocytes, adipocytes, chondrocytes and osteocytes, and they have been widely used in tissue engineering and tendon healing.
Exosomes are small membrane vesicles of endocytic origin that are secreted by most cells in culture. As one of the major pathways of extracellular signalling, exosomes have been implicated in many diseases and participated in many physiological processes. [7] [8] [9] [10] These are derived from fusion in cell to cell communication, as well as carriers of genetic information, which play an important role in inflammation and tissue repair when shuttled by exosomes. [11] [12] [13] Reports have showed that exosomes from mesenchymal stem cells (MSCs) become potential regenerative medicine application for tendinopathy.
14 Tendon stem cells are as a kind of MSCs, but effects of exosomes derived from TSCs on tendinopathy is unclear.
In this study, we reported that exosomes from TSCs balanced the matrix synthesis and degradation of the injury tendon and promoted the injury tendon healing. Exosomes from TSCs could be an ideal therapeutic strategy in tendon injury healing for its balancing tendon extracellular matrix and promoting the tenogenesis of TSCs.
| MATERIAL S AND ME THODS

| Ethics statement
Eight-week-old Sprague Dawley rats weighting 200-250 g were used and housed under a 12 hour light/dark cycle in a pathogen-free area with free access to water and food. All animals were treated according to institutional guidelines for laboratory animal treatment and care. All experimental procedures were approved by the Animal
Research Ethics Committee of the Third Military Medical University, China.
| Animal model establishment
A total of 18 male Sprague-Dawley rats (8 weeks old, 200-250 g)
were divided into three groups (six/group): control group, injury group with TSCs treatment and injury group with exosomes treatment. First, in the two injury groups, rats were injected with 30 µL type I collagenase solution (10 mg/mL) into both Achilles tendons to establish micro-damaged Achilles tendon model. After 1 week, rats in the injury group with TSCs treatment were injected by TSCs into the left injury site (PBS/right side), and rats in the injury group with exosomes treatment were injected by exosomes (twice a week) into the left injury site (PBS/right side). After 4 weeks, the tendon samples were collected for the next studies.
| Histomorphometry
Achilles tendon specimens were fixed in 4% paraformaldehyde. Nine sections were cut at a thickness of 4 mm and stained with haematoxylin and eosin. To analyse the changes of total histological scores on haematoxylin and eosin-stained slides after treatment, we used the established histological scoring system by Stoll 15 et al. The score of the intact group was defined as 20 points.
| Isolation and identification of exosomes
The isolation followed the multistep ultracentrifugation process as previously described. 16 We finally isolated 1 mL exosomes (resuspended in PBS) from 1000 mL of TSCs culture medium. When the fusion rate of TSCs reached 70%-80%, we changed the medium as the medium without foetal bovine serum (FBS). After 24 hours, the TSCs culture medium were ultilized for the isolation of exosomes. In our study, conditioned medium with exosomes (CM + Exo), conditioned medium without exosomes (CM − Exo) and exosomes were collected for treating TSCs ( Figure 1A ).
Identification of exosomes was through transmission electron microscope (TEM), particle diameter analysis and Western blotting for specific markers.
| Isolation, identification and culture of rat TSCs
Isolation of rat TSCs were performed as our previously described. For CM ± Exo treated analysis, after seeding for 24 hours, we changed the two wells of four as CM − Exo and CM + Exo. After that, we added with or without 10 ng/mL interleukin 1 beta (IL-1β;
PeproTech, Rocky Hill, NJ). For exosomes treated analysis, after seeding for 24 hours, 10 ng/mL IL-1β were added into TSCs for 1 hour, and then exosomes was added. After 48 hours, TSCs were collected for the next study.
| Tri-lineage differentiation assay
Multidifferentiation potential of TSCs was tested under tenogenic, adipogenic and osteogenic induction according to previously described. 17 Briefly, tenogenic differentiation of TSCs was induced with low glucose DMEM (LG-DMEM) supplemented with ascorbic acid (25 μmol/L) (Sigma, USA) and connective tissue growth factor (CTGF; 25 ng/mL) (Human CTGF; PeproTech). Adipogenic and osteogenic induction medium were purchased (Cyagen, Suzhou). The medium was changed every 3 days. After 2 weeks, TSCs were assessed by Sirius red staining, oil red staining and Alizarin red staining.
| Protein extraction and Western blotting
The Proteins were visualized and images captured using a LiCor
Odyssey Imager (LI-COR Biosciences, Lincoln, NE).
| Immunostaining
Serial coronal frozen sections (5 μm thick) were prepared from Achilles tendons as previously described. 
| Biomechanical analysis
We followed the procedures as described in previous study. 18 The
Achilles's tendon with bony end was first isolated. The two bony ends of tendon were fixed on a custom-made testing jig with two clamps. The lower one was used to fix the calcaneus end while the upper one was used to fix the tibia end. The whole construct was then mounted onto the mechanical testing machine.
| Statistical analysis
All values were expressed as mean ± standard deviation (SD). The Student's t test was used to compare between two groups. Multiple comparisons were made using a one-way ANOVA followed by Fisher's tests. A P-value of <0.05 was considered to be statistically significant. 
| RE SULTS
| Identification of TSCs
| Isolation and identification of exosomes from TSCs
To Results of Western blotting confirmed that vesicles expressed specific markers of CD63 and CD81 ( Figure 2D ).
| TSCs injection promoted the injury tendon healing
To evaluate the therapeutic effects of TSCs on tendinopathy, we in- Figure 3D ). Maximum loading and ultimate stress in TSCs group were lifted significantly compared with injury group (P = 0.0041 and P = 0.0108; Figure 3E -H).
| TSCs culture medium deficient in exosomes promoted the tendon matrix maintenance in vitro
To make clear that whether exosomes or cytokines exert the effect on 
| Exosomes derived from TSCs promoted the tendon matrix maintenance in vitro
Next, we evaluated the effect of exosomes derived from TSCs on tendon matrix maintenance through immunostaining analysis and Western blotting. We added exosomes into TSCs before IL-1β pretreatment for 0.5 hour. Immunostaining showed that MMP3 expression in the exosomes treated group significantly decreased(P = 0.0182), and the TIMP3 and Col-1a1 expression in this group significantly increased(P = 0.0020 and P = 0.0470) (Figure 5A-L) . Meanwhile, Western blotting showed that TNMD and Col-1a1 expression increased and MMP3 expression decreased after exosomes' adding ( Figure 5M ).
| Exosomes derived from TSCs promoted injury tendon healing
At last, we observed the effect of the exosomes derived from
TSCs on alleviation of tendinopathy ( Figure 6A ). From the haematoxylin and eosin staining, we found that the arrangement of collagens in exosomes group were more uniform than that of injury group ( Figure 6B ). The quantification results of histological score showed that exosomes treatment significantly increased the score after tendon injury (P < 0.0001; Figure 6C ). Immunostaining results also revealed that MMP3 was lowered and TIMP3 and Col-Ia1 were elevated by exosomes, which was in accordance with that in vitro ( Figure 6D ). Finally, we conducted the biomechanical analysis test, which showed that maximum loading and ultimate stress in exosomes group were significantly higher than that in injury group (P = 0.0117 and P = 0.0112; Figure 6E -H).
| D ISCUSS I ON
To restore structure and function of injury tendon is a big challenge in sports medicine because the understanding of tendon biology, and the molecular mechanisms controlling the migration, proliferation and fate of TSCs during tendon repair are lacking. Generally, the process of tendon healing includes three phases. 19 First, inflammatory cells especially neutrophils are gathered to the injury site, and collagen-III synthesis is initiated. Then, proliferative phase begins, and after 6 weeks, the remodelling phase commences. Although tendon has the ability of selfheal through the process above, the healed tissue never match the biochemical and mechanical properties of intact tendon.
20
It is well reported that the TSCs and their cytokines executed many therapeutic effects on tendon injury healing process.
Solaiman Tarafder 
CO N FLI C T O F I NTE R E S T
No competing financial interests exist among any authors in relation to this submission. 
AUTH O R CO NTR I B UTI O N S
DATA AVA I L A B I L I T Y S TAT E M E N T
The authors declare that the data supporting the findings of this study are available within the article.
O RCI D
Yunjiao Wang
https://orcid.org/0000-0003-1108-7079
Kanglai Tang https://orcid.org/0000-0002-0370-106X
